直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Seminar

Patent Monetization

November 12, 2014

Taipei, Taiwan

Finnegan’s Fei Han Foreign Legal Affairs Law Firm invites you to attend the next event of its program series. This afternoon program features two Finnegan partners, who will discuss generating revenue from your IP assets.

More companies today are reviewing their IP portfolios and finding that they possess significant IP assets. And they wish to generate revenue from those assets, just as they do with other corporate assets. This is a relatively new process for many corporate legal departments, as they typically have not viewed their IP assets as revenue drivers. Using examples from past experience, we will discuss ways that corporate IP assets can be deployed to add to the bottom line of the asset owner, including techniques we have seen work, and a few that we have seen not work.

Please join us as we discuss:

I. Understanding and strategically developing the scope of your IP portfolio and its significance in your industry

a. Who are the main competitors in your industry?
b. How IP-centric is your industry?
c. Does your IP give you product advantages in key markets?
d. What are the patent landscapes regarding your products and your IP assets?
e. What steps can be taken to strategically develop the portfolio?

II. Developing a strategy that is:

a. Consistent with corporate goals
b. Based on your current IP posture
c. Consistent with the reality of IP valuation and current legal landscapes

III. Implementing your IP development and monetization strategy

a. Litigation based monetization
b. Selling a large portfolio
c. Licensing a large portfolio
d. Private auction of smaller portfolios
e. Licensing of smaller portfolios
f. Patent pooling arrangements
g. Challenges which arise in IP monetization programs

RSVP:

Please RSVP by Friday, November 7, 2014. This event is free of charge; space is limited to three registrants per company.
Online at www.finnegan.com/multidayeventregistrationform3
E-mail at ipeventstaiwan@finnegan.com
For more information, please contact Ms. Nori Chen at (02)2712-7001 Ext. 113

Moderator:

Gary C. Ma

Speakers:

John C. Paul
Roger D. Taylor

Date & Location:

Wednesday, November 12, 2014
Sherwood Taipei, Yuan Ming Room,
3rd floor
台北西華飯店 三樓元明聽
No. 111, Section 3, Minsheng E. Rd., 105 Taipei
台北市民生東路三段111號

Time:

Registration: 13:30-14:00
Seminar: 14:00-16:15
Reception: 16:15-16:45

Related Practices

智財權申請及組合管理

Related Offices

Taipei

Related Professionals

馬 宗 聖
合夥人
Taipei
+886 2 2712 7001
Email
John C. Paul
Partner
Washington, DC
+1 202 408 4109
Email

Related Insights

Conference

7th International Conference on Biofuels and Bioenergy

June 25-26, 2026

Edinburgh

Conference

IPBC Global 2026

June 15-17, 2026

San Diego

Conference

17th Summit on Biosimilars & Innovator Biologics

June 2-3, 2026

New York

Articles

Article_D.-Mass-Patent-Litigation-Update-October-2024

D. Mass. Patent Litigation Update: April 2026

June 1, 2026

At the PTAB Blog

Consistency Is Key – USPTO Issues Three New Informative Decisions

May 29, 2026

At the PTAB Blog

Discretion All the Way Down: USPTO Uses a Discretionary IPR Denial to Justify a    
§ 325(d) EPR Denial

May 28, 2026

At the PTAB Blog

Claim Disclaimer Derails Instituted IPR in Freightcar America

May 26, 2026

At the PTAB Blog

IPR and PGR Statistics for Final Written Decisions Issued in March and April 2026

May 26, 2026

At the PTAB Blog

Before the Holding, the Message: Director Squires Uses Magnolia Medical to Outline PTAB Discretionary Denial Policy Changes

May 20, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP